Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: Randomised controlled trial

Lancet

Volumn 362, Issue 9378, 2003, Pages 95-102

  Houghton, Joan ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ADULT; AGED; ARTICLE; AUSTRALIA; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SURGERY; CARCINOMA IN SITU; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HISTOLOGY; HUMAN; INFORMED CONSENT; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; NEW ZEALAND; PRIORITY JOURNAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; TREATMENT FAILURE; UNITED KINGDOM;

EID: 0038304773     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)13859-7     Document Type: Article

References (12)

1. Anderson T.J., Lamb J., Donnan P., et al. Comparative pathology of breast cancer in a randomised trial of screening. Br J Cancer. 64:1991;108-113.
2. Veronesi U., Salvadori B., Luini A., et al. Breast conservation is a safe method in patients with small cancer of the breast. Long-term results of three randomised trials on 1,973 patients. Eur J Cancer. 31A:1995;1574-1579.
3. Fisher B., Redmond C., Poisson R., et al. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 320:1989;822-828.
4. Van Dongen J.A., Bartelink H., Fentiman I.S., et al. Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC Trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer. Eur J Cancer. 28A:1992;801-805.
5. Jacobson J.A., Danforth D.N., Cowan K.H., et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med. 332:1995;907-911.
6. Cuzick J., Baum M. Tamoxifen and contralateral breast cancer. Lancet. 2:1985;282.
7. Fornander T., Cedermark B., Mattson A., et al. Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers. Lancet. 2:1989;1070-1073.
8. Fisher B., Dignam J., Wolmark N. Tamoxifen in the treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised control trial. Lancet. 353:1999;1993-2000.
9. Fisher B., Dignam J., Wolmark N., et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol. 16:1998;441-452.
10. Julien J.P., Bijker N., Fentiman I.S. Radiotherapy in breast conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase 3 trial 10853. Lancet. 355:2000;528-533.
11. Fisher E.R., Dignam J., Tan-Chiu E., et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) 8 year up-date of protocol B-17. Cancer. 86:1999;429-438.
12. Silverstein M.J., Lagios M.D., Groshen S., et al. The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med. 340:1999;1455-1461.